Cargando…
Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study
INTRODUCTION: Sentinel lymph node biopsy (SLNB) is a diagnostic procedure developed in the 1990s. It is currently used to stage patients with primary cutaneous melanoma, provide prognostic information and guide management. The Australian Clinical Practice Guidelines state that SLNB should be conside...
Autores principales: | Rapport, Frances, Smith, Andrea L, Cust, Anne E, Mann, Graham J, Watts, Caroline G, Gyorki, David E, Henderson, Michael, Hong, Angela M, Kelly, John W, Long, Georgina V, Mar, Victoria J, Morton, Rachael L, Saw, Robyn PM, Scolyer, Richard A, Spillane, Andrew J, Thompson, John F, Braithwaite, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050375/ https://www.ncbi.nlm.nih.gov/pubmed/32111612 http://dx.doi.org/10.1136/bmjopen-2019-032636 |
Ejemplares similares
-
Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework
por: Smith, Andrea L., et al.
Publicado: (2022) -
Clinician attitudes towards cancer treatment guidelines in Australia
por: Bierbaum, Mia, et al.
Publicado: (2023) -
Systematic development of quality indicators for skin cancer management in primary care: a mixed-methods study protocol
por: Laginha, Bela Ines, et al.
Publicado: (2022) -
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
por: Miller, James R., et al.
Publicado: (2023) -
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)
por: Saw, Robyn PM, et al.
Publicado: (2014)